Highlights of ASH 2020-Virtual Conference

February 19, 2021


The field of hematology has been rapidly evolving. This continuing medical education activity will discuss new developments in the diagnosis and treatment of malignant and non malignant hematological disorders, as presented at the 2020 Annual Meeting of the American Society of Hematology (ASH).  At this one-day course, faculty will share the latest updates in myeloid malignancies, lymphoma, leukemia, multiple myeloma, coagulation disorders, and stem cell transplantation. Through presentations and Q & A, attendees will gain a deeper understanding of emerging treatments available for hematological malignancies and blood disorders and learn how these new therapies can be integrated into daily practice.


AHN Physicians$80.00
Nursing and Others$65.00
AHN Nursing and Others$45.00
Residents and FellowsComplimentary


Target Audience

This conference is intended for primary care physicians, hematologists and medical oncologists, fellows, residents, CRNP’s, PA’s, nurses and all other healthcare providers.

Learning Objectives



  1. Provide an overview and highlight the cutting-edge data presented at the 2020 Annual Meeting of the American Society of Hematology (ASH).
  2. Identify updates in molecular abnormalities which can be utilized in the diagnosis, prognosis, risk stratification, and therapy selection for patients with myeloid malignancies.
  3.  Discuss and assess the relevant clinical trial data in clinical practice which has the potential to improve outcomes in patients with malignant hematologic disorders including non-Hodgkin’s  lymphoma, CLL, and multiple myeloma.
  4. Review the updates in sequencing strategies in the era of novel immunotherapies,

CAR-T, targeted therapies, and stem cell transplantation.

  1. Discuss the latest advances in coagulation and platelet disorders.


Additional Information

ASHConference STD_PC_AHN_FP.pdf50.96 KB
Course summary
Course opens: 
Course expires: 
Event starts: 
02/19/2021 - 8:00am
Event ends: 
02/19/2021 - 3:15pm

Course Director

Salman Fazal, MD

Assistant Professor, Temple University School of Medicine
Director, Cell Transplantation Program
Allegheny Health Network Cancer Institute
West Penn Hospital
Pittsburgh, PA


Invited Faculty

John Mascarenhas, MD

Director, Adult Leukemia Program

Leader, Myeloproliferative Disorders Clinical Research Program

Tisch Cancer Institute, Division of Hematology/Oncology

Associate Professor of Medicine

Icahn School of Medicine at Mount Sinai

New York, NY


Nikhil C. Munshi, MD

Kraft Family Chair

Director of Basic and Correlative Science, Jerome Lipper Multiple Myeloma Center

Professor of Medicine, Harvard Medical School

Boston, Massachusetts


B. Douglas Smith, MD

Professor, Oncology - Division of Hematologic Malignancies

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Baltimore, Maryland




Physicians: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through joint providership of Allegheny General Hospital and Allegheny Health Network Cancer Institute West Penn Hospital.  Allegheny General Hospital is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Approved for AMA PRA Category 1 TM Credits.  Credits to be determined.


Exhibitors(active tab)VIRTUAL EXHIBIT HALL

Welcome to the Virtual Exhibit Hall. Analogous to booths at scientific conferences, this is a space where companies share information about their products and services, showcase their latest innovations, and connect with attendees, faculty and course directors. Check out the "booths" below to learn about each exhibitor and get connected!





The Virtual Exhibit Hall is paid advertising. The use of the Site and the Content, including Third Party Content, is at your own risk.








Please login or register to take this course.